Company Seelos Therapeutics, Inc.

Stocks

SEELQ

US81577F4063

Biotechnology & Medical Research

Market Closed - OTC Markets 12:25:32 2026-06-01 EDT			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-.--%	+9,900.00%

12-28	Motion for Asset Sale Approved for Seelos Therapeutics, Inc.	CI
25-10-21	GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q).	CI

Business description: Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. has ongoing preclinical programs, including SLS-004, SLS-006, and SLS-007. It has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.

Number of employees: 8

Sales by Activity: Seelos Therapeutics, Inc.

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Pharmaceuticals	375K	-	-	-	2.2M

See all business segments

Geographical breakdown of sales: Seelos Therapeutics, Inc.

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
United States	375K	-	-	-	2.2M

See all geographic segments

Executive Committee: Seelos Therapeutics, Inc.

Manager	Title	Age	Since
Raj Mehra CEO	Chief Executive Officer	66	2018-12-31
Michael Golembiewski DFI	Director of Finance/CFO	54	2021-08-31
Gopal Krishna CTO	Chief Tech/Sci/R&D Officer	-	-
Anthony Marciano IRC	Investor Relations Contact	-	2018-12-31

See SEELOS THERAPEUTICS, INC. governance

Company details: Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc.

300 Park Avenue

10022, New York

http://www.seelostherapeutics.com

address Seelos Therapeutics, Inc.(SEELQ)

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SEELOS THERAPEUTICS, INC.	+9,900.00%	-.--%	+9,900.00%	-100.00%	136
WUXI APPTEC CO., LTD.	+0.17%	+3.62%	+70.94%	+109.68%	73.25B
ARGENX SE	+1.73%	+13.43%	+57.10%	+90.54%	61.95B
INSMED INCORPORATED	+0.11%	-4.67%	+0.52%	+484.71%	28.02B
WUXI BIOLOGICS (CAYMAN) INC.	+5.24%	+5.33%	+57.01%	+17.77%	24.15B
BIONTECH SE	+1.26%	-0.05%	-18.30%	-18.08%	23.01B
PHARMAESSENTIA CORPORATION	-0.71%	+5.26%	+241.94%	+427.03%	18.35B
GENMAB A/S	0.00%	+5.62%	+40.50%	-15.26%	19.46B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.83%	+2.65%	+25.00%	+592.85%	15.92B
EXELIXIS, INC.	+1.53%	+0.30%	+38.66%	+152.95%	12.96B
Average	+991.32%	+1.11%	+1,041.34%	+174.22%	27.71B
Weighted average by Cap.	+1.25%	+3.43%	+57.13%	+166.73%